American journal of transplantation, 2022-05, Vol.22 (5), p.1291-1292
2022
Details
- Autor(en) / Beteiligte
- Titel
- Humoral immune responses against SARS‐CoV‐2 in transplantation: Actionable biomarker or misplaced trust?
- Ist Teil von
- American journal of transplantation, 2022-05, Vol.22 (5), p.1291-1292
- Ort / Verlag
- United States: Wiley Subscription Services, Inc
- Erscheinungsjahr
- 2022
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- Measures of vaccine‐specific antibodies to SARS‐CoV‐2, as discussed by Werbel and Segev (Page 1316), may ignore responses to contemporaneous variants of concern and relevant cellular immune responses, thereby failing to provide the insights required to optimize clinical care.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1600-6135eISSN: 1600-6143DOI: 10.1111/ajt.17018Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9111200
- Format
- –
- Schlagworte
- Antibodies, Antibodies, Viral, antibody biology, Biomarkers, COVID-19, editorial/personal viewpoint, Humans, immune regulation, Immune response (cell-mediated), Immune response (humoral), Immunity, Humoral, Immunocompetence, immunosuppression/immune modulation, infection and infectious agents—viral: SARS‐CoV‐2/COVID‐19, infectious disease, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Transplantation, Transplants & implants, Trust, Vaccination, vaccine